Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Lozenge for Oral Mucosal Pain
NCT01584947Phase 2Terminated
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Apr 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in burning mouth syndrome (BMS), Sjögren's syndrome, lichen planus (LP), sponsored by Copenhagen University Hospital - Hvidovre. Started Apr 2012; status: terminated.
02
Drugs
bupivacaine
03
Conditions
burning mouth syndrome (BMS)Sjögren's syndromelichen planus (LP)
Beyond the preview
Go deeper on NCT01584947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01584947.